Document is current
Any future updates will be listed below
-
Authors
Schoenmakers, Erik https://orcid.org/0000-0003-0674-8282
Marelli, Federica
Jørgensen, Helle F. https://orcid.org/0000-0002-7909-2977
Visser, W. Edward https://orcid.org/0000-0002-5248-863X
Moran, Carla https://orcid.org/0000-0002-7318-7166
Groeneweg, Stefan
Avalos, Carolina
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
Figg, Nichola
Finigan, Alison
Wali, Neha
Agostini, Maura
Wardle-Jones, Hannah
Lyons, Greta
Rusk, Rosemary
Gopalan, Deepa
Twiss, Philip
Visser, Jacob J.
Goddard, Martin
Nashef, Samer A. M.
Heijmen, Robin
Clift, Paul https://orcid.org/0000-0001-8906-7647
Sinha, Sanjay https://orcid.org/0000-0001-5900-1209
Pirruccello, James P. https://orcid.org/0000-0001-6088-4037
Ellinor, Patrick T. https://orcid.org/0000-0002-2067-0533
Busch-Nentwich, Elisabeth M.
Ramirez-Solis, Ramiro
Murphy, Michael P. https://orcid.org/0000-0003-1115-9618
Persani, Luca https://orcid.org/0000-0003-2068-9581
Bennett, Martin https://orcid.org/0000-0002-2565-1825
Chatterjee, Krishna https://orcid.org/0000-0002-2654-8854
- License Information
-
More Information
Article History
Received: 6 February 2023
Accepted: 22 November 2023
First Online: 2 December 2023
Competing interests
: PTE reports sponsored research support from Bayer AG, IBM Health, Bristol Myers Squibb and Pfizer and has consulted for Bayer AG, Novartis and MyoKardia. LP has consulted for Merck and Sandoz. MPM serves on the SAB of MitoQ Inc. Other authors have no conflicts of interest to declare.
